1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)
(
- Contribution to journal › Article
- 2008
-
Mark
Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report
(
- Contribution to journal › Article
- 2005
-
Mark
Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community-based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project
(
- Contribution to journal › Article
- 2001
-
Mark
Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes
(
- Contribution to journal › Article
- 2000
-
Mark
Pharmacoepidemiologic Studies of Diabetes Mellitus - with special reference to - Glucose Control and Prognosis of Type 2 Diabetes
2000)(
- Thesis › Doctoral thesis (compilation)
- 1997
-
Mark
Pharmacokinetics - Effect Relations of Glibenclamide and its Metabolites in Humans.
1997)(
- Thesis › Doctoral thesis (compilation)